Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases-Reference-Cited by-同舟云学术

Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases

Published:2015-01 Issue: Volume:37 Page:367-382
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Bartneck Matthias,Scheyda Katharina M.,Warzecha Klaudia T.,Rizzo Larissa Y.,Hittatiya Kanishka,Luedde Tom,Storm Gert,Trautwein Christian,Lammers Twan,Tacke Frank

Funder

RWTH Aachen

German Research Foundation

European Research Council

Interdisciplinary Center for Clinical Research (IZKF)

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference34 articles.

1. Pegylated liposomal doxorubicin: tolerability and toxicity;Goram;Pharmacotherapy,2001

2. Drug targeting systems for inflammatory disease: one for all, all for one;Crielaard;J Control Release,2012

3. Immunosuppression in the livers of mice with obstructive jaundice participates in their susceptibility to bacterial infection and tumor metastasis;Kawarabayashi;Shock,2010

4. Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages;Bartneck;Nanomedicine,2014

5. Steroid use in acute liver failure;Karkhanis;Hepatology,2014

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems;ACS Nano;2024-07-31

2. Liposomal nano-carriers mediated targeting of liver disorders: mechanisms and applications;Journal of Liposome Research;2024-07-10

3. Biomaterial-mediated intracellular control of macrophages for cell therapy in pro-inflammatory and pro-fibrotic conditions;Biomaterials;2024-07

4. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives;International Journal of Pharmaceutics;2024-07

5. Nano-drug-based Targeted Therapy Alleviates Ferroptosis-induced Liver Toxicity;Current Nanoscience;2024-07